- Home
- DLB vs RVMD Comparison
DLB vs RVMD Comparison
Compare DLB & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLB
- RVMD
- Stock Information
- Founded
- DLB 1965
- RVMD 2014
- Country
- DLB United States
- RVMD United States
- Employees
- DLB N/A
- RVMD N/A
- Industry
- DLB Multi-Sector Companies
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DLB Miscellaneous
- RVMD Health Care
- Exchange
- DLB Nasdaq
- RVMD Nasdaq
- Market Cap
- DLB 7.9B
- RVMD 7.5B
- IPO Year
- DLB 2005
- RVMD 2020
- Fundamental
- Price
- DLB $76.08
- RVMD $37.19
- Analyst Decision
- DLB Strong Buy
- RVMD Strong Buy
- Analyst Count
- DLB 4
- RVMD 12
- Target Price
- DLB $101.75
- RVMD $68.67
- AVG Volume (30 Days)
- DLB 388.8K
- RVMD 3.2M
- Earning Date
- DLB 08-06-2025
- RVMD 08-06-2025
- Dividend Yield
- DLB 1.74%
- RVMD N/A
- EPS Growth
- DLB 36.08
- RVMD N/A
- EPS
- DLB 2.64
- RVMD N/A
- Revenue
- DLB $1,320,184,000.00
- RVMD N/A
- Revenue This Year
- DLB $6.38
- RVMD N/A
- Revenue Next Year
- DLB $4.65
- RVMD $241.39
- P/E Ratio
- DLB $28.79
- RVMD N/A
- Revenue Growth
- DLB 4.03
- RVMD N/A
- 52 Week Low
- DLB $66.35
- RVMD $29.17
- 52 Week High
- DLB $89.66
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- DLB 56.60
- RVMD 39.61
- Support Level
- DLB $73.62
- RVMD $36.61
- Resistance Level
- DLB $75.04
- RVMD $38.18
- Average True Range (ATR)
- DLB 1.22
- RVMD 1.57
- MACD
- DLB 0.23
- RVMD -0.41
- Stochastic Oscillator
- DLB 93.83
- RVMD 12.08
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.